Photo Rounds

Recognition of skin cancer patterns

Author and Disclosure Information

 

This Photo Rounds aims to help you hone your visual diagnostic skills to recognize the 3 most common types of skin cancer (in order of prevalence): basal cell carcinoma, squamous cell carcinoma, and melanoma. (See also “Diagnosis of skin malignancy,”.)

Pattern recognition informs us about the initial differential diagnosis and the appropriate biopsy method.

Basal cell carcinoma

The most common basal cell carcinoma is nodular. Figure 1 shows nodular basal cell carcinoma with a raised pearly pink and white nodule with a smooth, shiny, translucent surface. The smooth surface reflects a loss of the normal pore pattern. Telangiectasias can be seen within the lesion, and the border may appear to be rolled.

Figure 2 shows a nodular basal cell carcinoma that is both pigmented and has some central ulceration. This figure demonstrates how difficult it is to distinguish a melanoma from a pigmented basal cell carcinoma.

Figure 3 shows the next most frequently seen basal cell carcinoma, the superficial basal cell carcinoma. These lesions are found most often on the trunk and extremities rather than the face, and may appear as a pink scaling plaque. Sometimes shallow crusts or erosions may be seen within the lesion. Note the thready border present around this scaling plaque. This slightly elevated border is the best tip-off to recognizing this scaling plaque as a skin cancer rather than a plaque of psoriasis or nummular eczema.

Figure 4 shows the least prevalent basal cell carcinoma, the sclerosing type. These lesions are often ivory-colored or colorless. The skin may be appear atrophic and feel indurated. A sclerosing basal cell carcinoma may resemble a scar and can be easily overlooked. These carcinomas are often called morpheaform because of the resemblance to localized scleroderma (morphea). They are also called infiltrating basal cell carcinoma because they infiltrate into the surrounding normal skin in a way not easily visible to the naked eye.

FIGURE 1

FIGURE 2
FIGURE 3
FIGURE 4

Pages

Recommended Reading

Screening decreases breast cancer-specific dealths but not all-cause mortality
MDedge Family Medicine
Caution necessary when interpreting results of outpatient endometrial sampling
MDedge Family Medicine
Hemoccult tests are insensitive for upper gastrointestinal cancer
MDedge Family Medicine
Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System
MDedge Family Medicine
Vasectomy not a risk factor for prostate cancer
MDedge Family Medicine
Information about tests for breast cancer: What are we telling people?
MDedge Family Medicine
Is a history of trauma associated with a reduced likelihood of cervical cancer screening?
MDedge Family Medicine
Cancer recurrence and mortality in women using hormone replacement therapy after breast cancer: Meta-analysis
MDedge Family Medicine
Benefits of tamoxifen for breast cancer prevention do not always outweigh overall risks
MDedge Family Medicine
Cancer risk assessment from family history: Gaps in primary care practice
MDedge Family Medicine